CF PharmTech

CF PharmTech Debt

The Debt of CF PharmTech (2652.HK) as of Oct 11, 2026 is 97.79 M CNY. In the previous year, Debt was 58.20 M CNY — a change of 68.03% (higher).

Debt

97.79 MCNY

YoY

68.03%

Last updated:

In 2025, CF PharmTech's total debt was 97.79 M CNY, a 68.03% change from the 58.20 M CNY total debt recorded in the previous year.

The CF PharmTech Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2022
240,000.00 CNY
Jan 1, 2023
19.20 M CNY
Jan 1, 2024
58.20 M CNY
Jan 1, 2025
97.79 M CNY
The CF PharmTech Debt history
YEARDebtYoY
97.79 MCNY+68.03%
58.20 MCNY+203.11%
19.20 MCNY+7,900.00%
240,000.00CNY—
Access this data via the Eulerpool API
Get Free API Key

CF PharmTech Stock analysis

What does CF PharmTech do? CF PharmTech is one of the most popular companies on Eulerpool.

Debt Details

Understanding CF PharmTech's Debt Structure

CF PharmTech's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing CF PharmTech's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to CF PharmTech’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in CF PharmTech’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about CF PharmTech stock

Debt of CF PharmTech is 97.79 M CNY in 2025.

Debt of CF PharmTech changed from 58.20 M CNY to 97.79 M CNY, representing a 68.03% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt CF PharmTech since 2006 – with annual values, charts, and detailed analysis.

Debt's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's CF PharmTech historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — CF PharmTech

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — CF PharmTech